Skip to main content
TEVA
NYSE Life Sciences

Teva Slides 7% as R&D Chief Eric Hughes Exits Mid-Pivot

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$39.18
Mkt Cap
$45.75B
52W Low
$24.01
52W High
$44.57
52W Position info
63% above low
Off High info
12% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

TEVA sits 63% above its 52-week low of $24.01.

Summary

Teva's EVP of Global R&D and Chief Medical Officer Eric Hughes resigned effective immediately after accepting an outside offer, and the stock fell nearly 7% Thursday. David Gardiner, currently head of Innovative Medicines & Clinical Development, takes over on an interim basis and reports directly to CEO Richard Francis while Teva launches an external search. The timing is awkward: Hughes' exit lands a week after Teva's first R&D Day, where it laid out $6-7B in innovative medicine revenue by 2030. Management says the R&D strategy and that 2030 target are unchanged, but losing the person who owned the pipeline is a real credibility test for the Pivot to Growth story. The move comes after a Q3 beat and raised guidance on November 3 and an at-home Igalmi label expansion on November 16, so this is the first negative headline in an otherwise strong run.

At the time of this announcement, TEVA was trading at $39.18 on NYSE in the Life Sciences sector, with a market capitalization of approximately $45.7B. The 52-week trading range was $24.01 to $44.57. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

TEVA - Latest Insights

TEVA
Nov 18, 2026, 5:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.21
Real-time Price: $39.04 info
Change: -$3.17 (-8%) info
Market Cap: $45.6B info
TEVA
Nov 16, 2026, 12:36 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $43.62
Real-time Price: $39.04 info
Change: -$4.58 (-10%) info
Market Cap: $45.6B info
TEVA
Nov 11, 2026, 12:33 PM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $42.86
Real-time Price: $39.04 info
Change: -$3.82 (-9%) info
Market Cap: $45.6B info
TEVA
Nov 03, 2026, 7:58 AM EST
Source: Seeking Alpha
Importance Score:
8
Price at Filing: $41.60
Real-time Price: $39.04 info
Change: -$2.56 (-6%) info
Market Cap: $45.6B info
TEVA
Oct 09, 2026, 11:21 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $41.62
Real-time Price: $39.04 info
Change: -$2.58 (-6%) info
Market Cap: $45.6B info